Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
International Journal of Colorectal Disease
Erschienen in: International Journal of Colorectal Disease 9/2010

01.09.2010 | Original Article

Practicability of quality goals for the treatment of rectal cancer

verfasst von: Sigmar Stelzner, Gunter Hellmich, Gunter Haroske, Erik Puffer, Thomas Jackisch, Helmut Witzigmann

Erschienen in: International Journal of Colorectal Disease | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In 2007, the German Working Group “Workflow Rectal Cancer II” published 19 quality indicators with 36 quality goals for the treatment of rectal cancer. We investigate whether these parameters are practicable in a specialized coloproctologic unit.

Patients and methods

We included 578 consecutive patients with rectal cancer who were treated in our institution from January 2000 to December 2008. Patient data were collected in a prospective database. Follow-up was conducted in a colorectal tumor clinic. Data were analyzed for the defined reference groups, and the results were compared with the quality goals.

Results

Median follow-up was 54.4 (range 1–116) months. We achieved 19 of the 36 defined quality goals. Among these were important parameters such as the rate of postoperative mortality (0.9%), the rate of intraoperative local tumor perforation (2.2% for anterior resection and 8.5% for abdominoperineal excision), the 5-year local recurrence rate (5.9% stages I–III), and the 5-year overall survival rates for stages yII and II (79.9%), and stages yIII and III (60.7%) for patients with microscopically negative resection margins.

Conclusion

Most of the defined quality goals can be achieved in a specialized coloproctologic unit. The debate on quality goals has the potential to enable further improvement in the care of rectal cancer patients.
Fußnoten
1
<12 cm from anal verge, stages (y)II and (y)III
 
Literatur
1.
Heald JR, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69:613–616CrossRefPubMed
2.
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed
3.
Schmiegel W, Pox C, Adler G, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Hohenberger W, Holstege A, Junginger T, Kühlbacher T, Porschen R, Propping P, Riemann JF, Sauer R, Sauerbruch T, Schmoll HJ, Zeitz M, Selbmann HK (2004) S3-guideline conference “Colorectal Cancer” 2004. Z Gastroenterol 42:1129–1177 (in German)CrossRefPubMed
4.
Bittner R, Burghardt J, Gross E, Grundmann RT, Hermanek P, Isbert C, Junginger T, Köckerling F, Merkel S, Möslein G, Raab HR, Roder J, Ruf G, Schwenk W, Strassburg J, Tannapfel A, de Vries A, Zühlke H (2007) Quality indicators for diagnostic and therapy of rectal carcinoma. Zentralbl Chir 132:85–94 (in German)CrossRefPubMed
5.
Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC (1991) Clinicopathological staging for colorectal cancer. An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 6:3225–3244CrossRef
6.
Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH, UICC (2003) TNM Supplement. A commentary on uniform use, 3rd edn. Wiley, New York
7.
Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
8.
Merkel S, Klossek D, Göhl J, Papadopoulos T, Hohenberger W, Hermanek P (2009) Quality management in rectal carcinoma: what is feasible? Int J Colorectal Dis 24:931–942CrossRefPubMed
9.
Mercury Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal adenocarcinoma: prospective observation study. BMJ 333:749–782CrossRef
10.
Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209–216PubMed
11.
Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, Cummings B, Gunderson L, Macdonald JS, Mayer RJ (2001) Impact of number of lymph nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157–163PubMed
12.
Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD (2006) Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 24:4078–4084CrossRefPubMed
13.
Doll D, Gertler R, Maak M, Friederichs J, Becker K, Geinitz H, Kriner M, Nekarda H, Siewert JR, Rosenberg R (2009) Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg 33:340–347CrossRefPubMed
14.
Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, Kiss D, Cecconello I (2008) Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 51:277–283CrossRefPubMed
15.
Madbouly KM, Remzi FH, Erkek BA, Senagore AJ, Baeslach CM, Khandwala F, Fazio VW, Lavery IC (2005) Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum 48:711–721CrossRefPubMed
16.
Borschitz T, Heintz A, Junginger T (2006) The influence of histopathologic criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: results of local excision (transanal endoscopic microsurgery) and immediate reoperation. Dis Colon Rectum 49:1492–1506CrossRefPubMed
17.
Tytherleigh MG, Warren BF, NJMc M (2008) Management of early rectal cancer. Br J Surg 95:409–423CrossRefPubMed
18.
Tarantino I, Hetzer FH, Warschkow R, Zünd M, Stein HJ, Zerz A (2008) Local excision and endoscopic posterior merorectal resection versus low anterior resection in T1 rectal cancer. Br J Surg 95:375–380CrossRefPubMed
19.
Borschitz T, Junginger T (2007) Progress report about the 1st Workshop on Local Excision of Rectal Cancer. Zentralbl Chir 132:99–105 (in German)CrossRefPubMed
20.
Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ, Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96:280–290CrossRefPubMed
21.
Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472CrossRef
22.
Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715CrossRefPubMed
23.
Strassburg J, Lewin A, Ludwig K, Kilian L, Linke J, Loy V, Knuth P, Püttcher O, Ruehl U, Stöckmann F, Hackenthal M, Hopfenmüller W, Huppertz A (2007) Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg 392:179–188CrossRefPubMed
24.
Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ (2003) Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg 90:999–1003CrossRefPubMed
25.
Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ (1997) Abdominoperineal excision of the rectum. An endangered operation. Dis Colon Rectum 40:747–751CrossRefPubMed
26.
Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, Dixon MF, Mapstone NP, Sebag-Montefiore D, Scott N, Johnston D, Sagar P, Finan P, Quirke P (2005) The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242:74–82CrossRefPubMed
27.
Nagtegaal ID, van de Velde CJ, Marijnen GC, van Krieken JHJM, Quirke P (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23:9257–9264CrossRefPubMed
28.
Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J (2007) Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94:232–238CrossRefPubMed
29.
West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P (2008) Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26:3481–3422CrossRef
30.
31.
Kruschewski M, Rieger H, Pohlen U, Hotz HG, Buhr HJ (2007) Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer. Int J Colorectal Dis 22:919–927CrossRefPubMed
32.
Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN, Norwegian Rectal Cancer Group (2005) Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis 7:51–57CrossRefPubMed
33.
Matthiessen P, Hallböök O, Andersson M, Rutegård J, Sjödahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 6:462–469CrossRefPubMed
34.
Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R (2007) Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer. Ann Surg 246:207–214CrossRefPubMed
35.
Peeters KC, Tollenaar RA, Marijnen CA, Klein-Kranenbarg E, Steup WH, Wiggers T, Rutten HJ, van de Velde CJ, Dutch Colorectal Cancer Group (2005) Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg 92:211–216CrossRefPubMed
36.
Karanjia ND, Corder AP, Bearn P, Heald RJ (1994) Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81:1224–1226CrossRefPubMed
37.
Chessin DB, Enker W, Cohen AM, Paty PB, Weiser MR, Saltz L, Minsky BD, Wong WD, Guillem JG (2005) Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg 200:876–882CrossRefPubMed
38.
Yeh CY, Changchien CR, Wang JY, Chen JS, Chen HH, Chiang JM, Tang R (2005) Pelvic drainage and other risk factors for leakage after elective anterior resection in rectal cancer patients. A prospective study of 978 patients. Ann Surg 241:9–1
39.
Bokey EL, Öjerskog B, Chapius PH, Dent OF, Newland RC, Sinclair G (1999) Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg 86:1164–1170CrossRefPubMed
40.
Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92:225–229CrossRefPubMed
41.
Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303–312CrossRefPubMed
42.
Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D, MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828CrossRefPubMed
43.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646CrossRefPubMed
44.
Moutardier V, Tardat E, Giovannini M, Lelong B, Guiramand J, Magnin V, Houvenaeghel G, Delpero JR (2003) Long-term results of preoperative radiotherapy for 113 cases of uT3 and uT4 rectal cancer: a need for long-term follow-up. Dis Colon Rectum 46:1194–1199CrossRefPubMed
45.
Murty M, Enker WE, Martz J (2000) Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer. Semin Surg Oncol 19:321–328CrossRefPubMed
46.
Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 240:260–268CrossRefPubMed
47.
Hohenberger W, Bittorf B, Papadopoulos T, Merkel S (2005) Survival after surgical treatment of cancer of the rectum. Langebecks Arch Surg 390:363–372CrossRef
48.
Cecil T, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in node positive rectal cancer. Dis Colon Rectum 47:1145–1150CrossRefPubMed
49.
Stelzner S, Hellmich G, Koch R, Witzigmann H (2009) Exactitude of relative survival in comparison to cause-specific survival and competing risk estimations based on a clinical database of colorectal carcinoma patients. Dis Colon Rectum 52:1264–1271PubMed
50.
Staib L, Link KH, Blatz A, Beger HG (2002) Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2,400 patients—monoinstitutional experience. World J Surg 26:59–66CrossRefPubMed
51.
Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, Öjerskog B, Damber L, Johansson R (2007) The Swedish rectal cancer registry. Br J Surg 94:1285–1292CrossRefPubMed
Metadaten
Titel
Practicability of quality goals for the treatment of rectal cancer
verfasst von
Sigmar Stelzner
Gunter Hellmich
Gunter Haroske
Erik Puffer
Thomas Jackisch
Helmut Witzigmann
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 9/2010
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-010-0965-y

Weitere Artikel der Ausgabe 9/2010

International Journal of Colorectal Disease 9/2010 Zur Ausgabe

Original Article

Chronic posterior tibial nerve transcutaneous electrical nerve stimulation (TENS) to treat fecal incontinence (FI)

Original Article

Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial?

Original Article

Clinicopathological characteristics of rectal carcinoids

Original Article

Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia–reperfusion

Letter to the Editor

Local excision of rectal cancer afterchemoradiation: feasibility depends on the primary stage

Original Article

Measurable learning effects after a 1-week skills course in digestive surgery

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.